These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 6323101

  • 1. Detection of HBeAg in the lymphocytes of sero-HBeAg negative patients with chronic hepatitis B and primary hepatocellular carcinoma.
    Ding JL, Oon CJ.
    Cytobios; 1984; 39(153):29-33. PubMed ID: 6323101
    [Abstract] [Full Text] [Related]

  • 2. Hepatitis B virus infection and hepatocellular carcinoma among parous Taiwanese women: nationwide cohort study.
    Fwu CW, Chien YC, Kirk GD, Nelson KE, You SL, Kuo HS, Feinleib M, Chen CJ.
    J Natl Cancer Inst; 2009 Jul 15; 101(14):1019-27. PubMed ID: 19535774
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Hepatitis Be antigen and antibody in chronic liver diseases and hepatocellular carcinoma.
    Chen DS, Sung JL, Lai MY.
    Hepatogastroenterology; 1981 Dec 15; 28(6):288-91. PubMed ID: 6284625
    [Abstract] [Full Text] [Related]

  • 5. Pre-S deletion and complex mutations of hepatitis B virus related to advanced liver disease in HBeAg-negative patients.
    Chen CH, Hung CH, Lee CM, Hu TH, Wang JH, Wang JC, Lu SN, Changchien CS.
    Gastroenterology; 2007 Nov 15; 133(5):1466-74. PubMed ID: 17915220
    [Abstract] [Full Text] [Related]

  • 6. [Hepatitis B virus DNA detection by means of polymerase chain reaction in patients with chronic hepatitis and hepatocellular carcinoma].
    Song Y, Pan W, Fan Z, Du P, Qi Z.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Sep 15; 11(3):220-2. PubMed ID: 15617333
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Immunosuppressive therapy in patients with HBeAg-positive chronic active hepatitis B?].
    Maier KP, Lepiorz H, Berthold H, Gerok W.
    Leber Magen Darm; 1982 Aug 15; 12(4):150-3. PubMed ID: 7132529
    [Abstract] [Full Text] [Related]

  • 11. A 13-year longitudinal study of the impact of double mutations in the core promoter region of hepatitis B virus on HBeAg seroconversion and disease progression in patients with genotype C chronic active hepatitis.
    Jang JW, Lee YC, Kim MS, Lee SY, Bae SH, Choi JY, Yoon SK.
    J Viral Hepat; 2007 Mar 15; 14(3):169-75. PubMed ID: 17305882
    [Abstract] [Full Text] [Related]

  • 12. Interferon-gamma production specific for hepatitis B virus antigen by intrahepatic T lymphocytes in patients with acute and chronic hepatitis B.
    Kakumu S, Ishikawa T, Wakita T, Yoshioka K, Takayanagi M, Tahara H, Kusakabe A.
    Am J Gastroenterol; 1994 Jan 15; 89(1):92-6. PubMed ID: 8273806
    [Abstract] [Full Text] [Related]

  • 13. Markers of disease activity in chronic hepatitis B virus infection.
    Yalcin K, Degertekin H, Yildiz F, Celik Y.
    Clin Invest Med; 2003 Feb 15; 26(1):27-34. PubMed ID: 12659467
    [Abstract] [Full Text] [Related]

  • 14. [The intrahepatic expression of the hepatitis B virus in chronic delta hepatitis].
    Ramalho F, Velosa J, Costa A, Baptista A, de Moura MC.
    Acta Med Port; 1993 May 15; 6(5):187-91. PubMed ID: 8337951
    [Abstract] [Full Text] [Related]

  • 15. [Morphologic findings in liver tissue in chronic active hepatitis B after seroconversion from HBeAg to anti-HBe].
    Chlumská A, Stránský J, Taimr P, Baumruk L, Nevaril M.
    Vnitr Lek; 1995 Jul 15; 41(7):445-8. PubMed ID: 7571477
    [Abstract] [Full Text] [Related]

  • 16. Natural history of hepatitis B.
    Marcellin P, Castelnau C, Martinot-Peignoux M, Boyer N.
    Minerva Gastroenterol Dietol; 2005 Mar 15; 51(1):63-75. PubMed ID: 15756147
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Can HBsAg levels guide to differentiate inactive HBsAg carriers from HBeAg negative chronic B hepatitis?].
    Sayan M, Mutlu B, Erdoğan S, Meriç M, Willke A.
    Mikrobiyol Bul; 2007 Jan 15; 41(1):87-93. PubMed ID: 17427556
    [Abstract] [Full Text] [Related]

  • 19. Cellular and humoral immune reactions in chronic active liver disease. II. Lymphocyte subsets and viral antigens in liver biopsies of patients with acute and chronic hepatitis B.
    Eggink HF, Houthoff HJ, Huitema S, Wolters G, Poppema S, Gips CH.
    Clin Exp Immunol; 1984 Apr 15; 56(1):121-8. PubMed ID: 6713726
    [Abstract] [Full Text] [Related]

  • 20. High rate of mutations in the hepatitis B core gene during the immune clearance phase of chronic hepatitis B virus infection.
    Bozkaya H, Ayola B, Lok AS.
    Hepatology; 1996 Jul 15; 24(1):32-7. PubMed ID: 8707278
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.